Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells.
Cutaneous melanoma is one of the highly malignant human tumours, due to its tendency to generate early metastases and its resistance to classical chemotherapy. We recently demonstrated that pamidronate, a nitrogen-containing bisphosphonate, has an antiproliferative and proapoptotic effect on different melanoma cell lines. In the present study, we compared the in vitro effects of three different bisphosphonates on human melanoma cell lines and we demonstrated that the two nitrogen-containing bisphosphonates pamidronate and zoledronate inhibited the proliferation of melanoma cells and induced apoptosis in a dose- and time-dependent manner. Moreover, cell cycle progression was altered, the two compounds causing accumulation of the cells in the S phase of the cycle. In contrast, the nonaminobisphosphonate clodronate had no effect on melanoma cells. These findings suggest a direct antitumoural effect of bisphosphonates on melanoma cells in vitro and further support the hypothesis of different intracellular mechanisms of action for nitrogen-containing and nonaminobisphosphonates. Our data indicate that nitrogen-containing bisphosphonates may be a useful novel therapeutic class for treatment and/or prevention of melanoma metastases.
1st Clinic of Dermatology, Colentina Hospital, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
A-M
AM
Forsea
C
C
Müller
C
C
Riebeling
C E
CE
Orfanos
C C
CC
Geilen
D000963:Antimetabolites / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects*; D004002:Clodronic Acid / Q000494:pharmacology*; D004164:Diphosphonates / Q000494:pharmacology*; D018450:Disease Progression; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D008545:Melanoma / Q000473:pathology*; D009584:Nitrogen; D000077268:Pamidronate; D012878:Skin Neoplasms / Q000473:pathology*; D014407:Tumor Cells, Cultured; D000077211:Zoledronic Acid
D000963:Antimetabolites; D000970:Antineoplastic Agents; D004164:Diphosphonates; D007093:Imidazoles; D004002:Clodronic Acid; D000077211:Zoledronic Acid; D009584:Nitrogen; D000077268:Pamidronate